Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Total Stockholders’ equity	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Operating Partnership Unitholders’ Non-controlling Interests
Beginning balance at Dec. 31, 2022	$ 283,711	$ 229,231	$ 195	$ 254,107	$ 7,486	$ (32,557)	$ 54,480
Beginning balance (in shares) at Dec. 31, 2022			19,555,272
Net proceeds from sale of common stock (in shares)			55,082
Net proceeds from sale of common stock	710	710	$ 1	709
Shares issued upon redemption of OP units (in shares)			22,798
Shares issued upon redemption of operating partnership units	0	409		409			(409)
Issuance and amortization of equity-based compensation (in shares)			146,627
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	1,945	1,377	$ 1	1,376			568
Issuance and amortization under ESPP (in shares)			6,446
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	94	94		94
Restricted stock withholdings (in shares)			(21,310)
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	327	327		327
Dividends and distributions	(5,963)	(4,787)				(4,787)	(1,176)
Unrealized loss on derivative instruments	(2,837)	(2,279)			(2,279)		(558)
Net income	433	348				348	85
Reallocation of non-controlling interest	0	(2,338)		(2,338)			2,338
Ending balance (in shares) at Mar. 31, 2023			19,764,915
Ending balance at Mar. 31, 2023	277,766	222,438	$ 197	254,030	5,207	(36,996)	55,328
Beginning balance at Dec. 31, 2022	283,711	229,231	$ 195	254,107	7,486	(32,557)	54,480
Beginning balance (in shares) at Dec. 31, 2022			19,555,272
Net income	1,694
Ending balance (in shares) at Jun. 30, 2023			20,029,975
Ending balance at Jun. 30, 2023	281,570	225,711	$ 200	258,331	7,934	(40,754)	55,859
Beginning balance at Mar. 31, 2023	277,766	222,438	$ 197	254,030	5,207	(36,996)	55,328
Beginning balance (in shares) at Mar. 31, 2023			19,764,915
Net proceeds from sale of common stock (in shares)			265,225
Net proceeds from sale of common stock	3,843	3,843	$ 3	3,840
Issuance of operating partnership units in connection with acquisition transactions	548						548
Cash redemption from non-controlling interests	(558)						558
Issuance and amortization of equity-based compensation (in shares)			(165)
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	1,242	684	$ 0	684			558
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	6	6		6
Dividends and distributions	(5,937)	(4,770)				(4,770)	(1,167)
Unrealized loss on derivative instruments	3,399	2,727			2,727		672
Net income	1,261	1,012				1,012	249
Reallocation of non-controlling interest	0	(229)		(229)			229
Ending balance (in shares) at Jun. 30, 2023			20,029,975
Ending balance at Jun. 30, 2023	281,570	225,711	$ 200	258,331	7,934	(40,754)	55,859
Beginning balance at Dec. 31, 2023	301,625	243,562	$ 219	287,268	4,621	(48,546)	58,063
Beginning balance (in shares) at Dec. 31, 2023			21,960,211
Net proceeds from sale of common stock (in shares)			576,087
Net proceeds from sale of common stock	7,867	7,867	$ 6	7,861
Issuance of operating partnership units in connection with acquisition transactions	5,788						5,788
Issuance and amortization of equity-based compensation (in shares)			120,941
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	2,113	1,148	$ 1	1,147			965
Issuance and amortization under ESPP (in shares)			5,137
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	77	77		77
Restricted stock withholdings (in shares)			(27,919)
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	396	396		396
Dividends and distributions	(6,859)	(5,520)				(5,520)	(1,339)
Unrealized loss on derivative instruments	2,819	2,267			2,267		552
Net income	256	206				206	50
Reallocation of non-controlling interest	0	(1,079)		(1,079)			1,079
Ending balance (in shares) at Mar. 31, 2024			22,634,457
Ending balance at Mar. 31, 2024	313,290	248,132	$ 226	294,878	6,888	(53,860)	65,158
Beginning balance at Dec. 31, 2023	301,625	243,562	$ 219	287,268	4,621	(48,546)	58,063
Beginning balance (in shares) at Dec. 31, 2023			21,960,211
Net income	1,288
Ending balance (in shares) at Jun. 30, 2024			22,744,912
Ending balance at Jun. 30, 2024	309,532	245,480	$ 228	296,886	6,899	(58,533)	64,052
Beginning balance at Mar. 31, 2024	313,290	248,132	$ 226	294,878	6,888	(53,860)	65,158
Beginning balance (in shares) at Mar. 31, 2024			22,634,457
Net proceeds from sale of common stock (in shares)			57,993
Net proceeds from sale of common stock	685	685	$ 1	684
Shares issued upon redemption of OP units (in shares)			52,778
Shares issued upon redemption of operating partnership units	0	862		861			(862)
Issuance and amortization of equity-based compensation (in shares)			(316)
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	1,433	722	$ 0	722			711
Issuance and amortization under ESPP (in shares)			0
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	6	6		6
Dividends and distributions	(6,928)	(5,490)				(5,490)	(1,438)
Unrealized loss on derivative instruments	14	11			11		3
Net income	1,032	817				817	215
Reallocation of non-controlling interest	0	(265)		(265)			265
Ending balance (in shares) at Jun. 30, 2024			22,744,912
Ending balance at Jun. 30, 2024	$ 309,532	$ 245,480	$ 228	$ 296,886	$ 6,899	$ (58,533)	$ 64,052